![](../../files/images/goods/1415251-36-3.png)
WJ460
CAS No. 1415251-36-3
WJ460 ( —— )
产品货号. M26864 CAS No. 1415251-36-3
WJ460 是肌成纤维蛋白的有效抑制剂。 WJ460 在乳腺癌细胞中发挥抗转移活性。
纯度: >98% (HPLC)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥1158 | 有现货 |
![]() ![]() |
10MG | ¥1968 | 有现货 |
![]() ![]() |
25MG | ¥3216 | 有现货 |
![]() ![]() |
50MG | ¥4836 | 有现货 |
![]() ![]() |
100MG | ¥7031 | 有现货 |
![]() ![]() |
500MG | ¥14337 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称WJ460
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述WJ460 是肌成纤维蛋白的有效抑制剂。 WJ460 在乳腺癌细胞中发挥抗转移活性。
-
产品描述WJ460 is an effective inhibitor of myoferlin. WJ460 exerts anti-metastatic activity in breast cancer cells.(In Vitro):WJ460 dose-dependently blocks breast cancer cell invasion through Collagen I(IC50: 43.37?nM in MDA-MB-231 and 36.40 nM in BT549 cells).(In Vivo):In a spontaneous metastasis model, WJ460 inhibits angiogenesis, breast tumor growth, and spontaneous metastasis .
-
体外实验——
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Adrenocorticotropic hormone (ACTH)
-
研究领域——
-
适应症——
化学信息
-
CAS Number1415251-36-3
-
分子量460.59
-
分子式C27H28N2O3S
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESO=C(NCCCCC=1C=CC=CC1)C2=CC=CC(=C2)C3SCC(=O)N3C=4C=CC=CC4OC
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Francesco Iuliano, et al. Adding Slow Release Tetracosactide Acetate to Eltrombopag Improves Haematological Response in ITP Patients with Platelet-Count Fluctuation.
产品手册
![](/themes/theme/en/images/ct.png)
![](/themes/theme/en/images/new12.jpg)
![](/themes/theme/en/images/gift.jpg)
![](/themes/theme/en/images/ct2.png)
关联产品
-
Oil Red O
干染料油红 O 用于制备染色溶液,可用于检测组织学冷冻切片中的脂质。
-
Cannabidiol hydroxyq...
Cannabidiol hydroxyquinone(HU-331) might be an active metabolite of cannabidiol potentially contributing to the induction of apoptosis.
-
Dammarenediol II
Dammarenediol II may have the ability to prevent diabetic microvascular complications, including diabetic retinopathy.